 |
 |
| 序号 | 股票 | 持股数量(股) | 持股变动 | 占总股本比例 | 报告期 | |
| 1 | 昭衍新药 | 155016 | 减持 | 0.999 | 0.0208% | 2026-09-30 |
| 2 | 昭衍新药 | 168616 | 增持 | 0.999 | 0.0225% | 2026-06-30 |
| 3 | 昭衍新药 | 154816 | 增持 | 0.999 | 0.0207% | 2026-03-31 |
| 4 | 昭衍新药 | 152016 | 增持 | 0.999 | 0.0203% | 2025-12-31 |
| 5 | 昭衍新药 | 144916 | 减持 | 0.999 | 0.0193% | 2025-09-30 |
| 6 | 昭衍新药 | 164416 | 减持 | 0.999 | 0.0219% | 2025-06-30 |
| 7 | 昭衍新药 | 174816 | 减持 | 0.999 | 0.0233% | 2024-12-31 |
| 8 | 昭衍新药 | 178116 | 减持 | 0.999 | 0.0238% | 2024-06-30 |
| 9 | 昭衍新药 | 189016 | 增持 | 0.999 | 0.0252% | 2023-12-31 |
|
|